Application of 3-bromopyruvic acid in preparation of drug for treating pulmonary arterial hypertension

A technology of pulmonary hypertension and bromopyruvate, which is applied in drug combinations, active ingredients of anhydride/acid/halide, cardiovascular system diseases, etc., can solve problems such as poor efficacy, reduce pulmonary vascular remodeling, and increase cardiac output The effect of promoting apoptosis

Inactive Publication Date: 2017-05-31
张锐
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The object of the present invention is to provide the application of 3-bromopyruvate in the preparation of the medicine for the treatment of pulmonary hypertension, and the application of the described 3-bromopyruvate in the preparation of the medicine for the treatment of pulmonary hypertension will solve the problem of treatment in the prior art. Technical Problems with Ineffective Drugs in Pulmonary Arterial Hypertension

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 3-bromopyruvic acid in preparation of drug for treating pulmonary arterial hypertension
  • Application of 3-bromopyruvic acid in preparation of drug for treating pulmonary arterial hypertension
  • Application of 3-bromopyruvic acid in preparation of drug for treating pulmonary arterial hypertension

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] 1. Materials and methods

[0017] 1.1 Establishment of Rat Pulmonary Hypertension Model

[0018] Male SPF grade SD rats (provided by the animal room of Shanghai Chinese Academy of Sciences), weighing 200-220g. One-time subcutaneous injection of monocrotaline (Monocrotaline, MCT, 60mg / kg), 3 weeks later, right heart catheterization was used randomly to measure pulmonary artery pressure and hemodynamic parameters to identify whether the model was successfully established.

[0019] 1.2 Experimental grouping and drug intervention

[0020] (1) Model group (MCT group): 10 rats were given normal saline by intragastric administration after the pulmonary hypertension model was successfully established for 3 consecutive weeks.

[0021] (2) 3-bromopyruvate low-dose group (3-BrPA 15mg·kg·d group): 10 rats were given Tongxinluo by intragastric administration after the successful establishment of the pulmonary arterial hypertension model for 3 consecutive weeks.

[0022] (3) 3-bro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the pharmaceutical chemistry field and provides application of 3-bromopyruvic acid in preparation of a drug for treating pulmonary arterial hypertension. Experiments prove that 3-bromopyruvic acid is capable of effectively decreasing average pulmonary arterial pressure and pulmonary vascular resistance of mice with the pulmonary arterial hypertension, increasing cardiac output, inhibiting the abnormal proliferation of pulmonary arterial smooth muscle cells and promoting the apoptosis and remarkably relieving pulmonary vascular remodeling, and the pulmonary arterial hypertension can be treated by inhibiting the expression of hexokinase.

Description

[0001] Technical field: [0002] The invention belongs to the field of medicinal chemistry, and relates to a chemical medicine 3-bromopyruvate, specifically the application of 3-bromopyruvate in preparing medicine for treating pulmonary hypertension. [0003] Background technique: [0004] 3-Bromopyruvate is an alkylating agent, which is an analog of cell metabolites pyruvate and lactic acid, which can act on the glycolytic pathway and bind to the -XH group of the active site of hexokinase (HK-2) ( EXH+BrCH 2 -CO-COOH→EX-CH 2 -CO-COOH+HBr) inhibits the activity of the enzyme, which can effectively reduce the production of ATP in cells. 3-Bromopyruvate is very similar to lactic acid in terms of chemical properties and structure, and lactic acid is the final product of glucose after glycolytic metabolism, which allows 3-bromopyruvate to enter and exit cells through the same carrier as lactic acid, thereby exerting Antitumor effect. 3-Bromopyruvate has high efficiency and low ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/19A61P11/00A61P9/12
CPCA61K31/19
Inventor 张锐张云龙刘锦铭王岚赵勤华张宏达
Owner 张锐
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap